Saturday, September 27, 2008

Novartis Rolls Out Educational Dinner Meeting Series for GP Dentists

East Hanover, NJ, September 25, 2008 — Novartis Pharmaceuticals Corporation today announced the launch of a complimentary dental industry-focused dinner meeting series entitled “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals.”

The dinner meetings are designed as an adjunct to Novartis’ recently-launched web seminar series and are being offered for dentists who prefer live seminars and the opportunity to interact with the presenters as well as their peers.

A total of ten 2-hour dinner meetings (www.oralhealthdinnermeeting.com) are to be hosted between September and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.

“Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals” will cover the following topics that every general practice dentist needs to know:

• Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic
bone disease
• Osteonecrosis of the jaw (ONJ) background
• ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
• Review of ONJ studies and management



The convenient schedule for the 10 Novartis dinner meetings is as follows:

City Date Time

New Jersey Tues -10/14 7:00 PM
Philadelphia Thurs -10/16 7:00 PM
New York City Tues -10/21 7:00 PM
Boston Thurs -10/23 7:00 PM
Miami Tues -10/28 7:00 PM
Chicago Thurs -10/30 7:00 PM
Detroit Weds -11/05 7:00 PM
Dallas Thurs -11/06 7:00 PM
Los Angeles Weds - 11/12 7:30 PM
San Francisco Thurs -11/13 7:00 PM

For more details and to register for any dinner meeting session of “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals,” visit www.oralhealthdinnermeeting.com.

Post a Comment